Monoclonal Antibody Treatment for COVID-19

There is emerging evidence for the efficacy of monoclonal antibody (mAb) treatment for early COVID disease. Both Lilly and Regeneron have conducted randomized control trials to test this intervention. Based on the initial results of these trials, the FDA gave an EUA for both treatments with a set of inclusion criteria to focus the treatment … Continue reading Monoclonal Antibody Treatment for COVID-19

PowerForward: a New Tech Ed Program

The Hidary Foundation has now launched several tech education pilot programs across several schools in New York & New Jersey. We are pioneering a new model for k-12 tech education based on immersive bootcamp-style programs, with a special focus on encouraging female students to pursue STEM pathways. Aside from routinely advising these schools on strategies … Continue reading PowerForward: a New Tech Ed Program

Hidary Foundation co-funding new Cancer Study with MRA

Melanoma Research Alliance and the Hidary Foundation Fund Research Study of Melanoma Genomics Scientific Investigators at 5 Institutions Receive $1 Million to Spur Better Outcomes for Patients with Acral Melanoma and Provide Breakthroughs Through the Use of Genome Sequencing December 03, 2013 10:00 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)--The Melanoma Research Alliance (MRA), the leading … Continue reading Hidary Foundation co-funding new Cancer Study with MRA